Virtual Visit to Manage Blood Thinners Around Surgery
Part of Heart & circulation clinical trials.
This study looks at whether a virtual visit can safely manage your blood thinners around the time of a planned surgery. You would stop your medication before the procedure and restart it after, but all instructions and check-ins happen remotely (phone or video).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have atrial fibrillation (AFib) or atrial flutter and take blood thinners for it
- You take warfarin with a target INR of 2-3, OR a standard-dose DOAC (apixaban 2.5/5 mg twice daily, edoxaban 30/60 mg daily, dabigatran 110/150 mg twice daily, or rivaroxaban 15/20 mg daily)
- You have a planned (non-urgent) surgery or procedure coming up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
This trial tests whether people with atrial fibrillation who have had a successful ablation procedure can safely stop taking blood thinners (NOACs) if they wear a monitor to check for any silent heart rhythm problems. It may help you avoid the risks of long-term blood thinner use if your ablation has been effective.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.